A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples